In systemic lupus erythematosus (SLE) ST2825 abolished production of autoantibodies in peripheral blood mononuclear cells from SLE patients stimulated with TLR9 agonist CpG which enables further human clinical testing [126]. The gene discussed is TLR9; the disease is systemic lupus erythematosus.